As AI models become more deeply embedded across functions at biopharmaceutical companies, it is crucial to effectively manage the associated risks of data privacy and security, bias and fairness, regulatory compliance, and reliability and performance.
- The Power of Putting People First in Driving Business Growth
- Pricing For Rare Disease Therapies And Cures: What’s Fair?
- Meaningful Industry Change Means Balancing Tech And Human Touch
- Building On Direct-To-Patient Marketing For Improved Access To Therapeutics
- Where Are They Now? SQZ Biotech
- Take-Home Microdosing Trial Studies Sub-Hallucinogenic For Depression
- Reviva Pharma’s Novel Funding Approach In Schizophrenia
- Companies To Watch: OSE Immunotherapeutics
COMPANIES TO WATCH
-
Companies To Watch: OSE Immunotherapeutics
OSE Immunotherapeutics is poised to begin a confirmatory and pivotal Phase 3 trial for a novel cancer vaccine targeting the second line in NSCLC, an area of acute unmet need.
-
Antiva Biosciences is exploring a local and global opportunity with a topically administered HPV treatment.
-
A novel small molecule developer aims to shake up the solid tumor treatment landscape.
-
Founded in late 2019, KeifeRx is repurposing oncology drugs for neurodegenerative disorders.
WHERE ARE THEY NOW
-
Where Are They Now? SQZ Biotech
SQZ Biotech, a novel cell therapy company with Big Pharma backing, is no more. However, the company's science, and its founding CEO, will continue on under new auspices.
-
Where Are They Now? Novo Nordisk
In a few short years, Novo Nordisk has gone from belt-tightening to parachute pants, and is now replaying a GLP-1 competition with Eli Lilly that kicked off with Victoza and Trulicity ten years ago.
-
Where Are They Now? Ono Pharmaceuticals
Ono Pharmaceuticals continues its quest to become a global biopharmaceutical company, after discovering and helping to launch one of the most successful cancer drugs, Opdivo, in the last decade.
NEWSLETTER ARCHIVE
- 05.15.24 -- Putting People First For Business Growth
- 05.14.24 -- Let's deviate from deviations - Sterile drugs.
- 05.13.24 -- CEOs On Navigating Growth And Progressing Immuno-Oncology
- 05.10.24 -- What Is A Fair Drug Price For Rare Diseases?
- 05.09.24 -- Mastering Site-Relationship Strategies In Today's Autonomous Landscape